The second part of the theory, i.e., the prediction that overactive TLR-signaling at later stages of COVID-19 disease would result in symptoms mimicking a TLR7-driven SLE-flare, is now also supported by ample observational evidence. Here, TLR7 is linked to systemic lupus erythematosus.